Platelet Rich Plasma Therapy in Achilles and Patellar Tendinopathies: Outcomes in Subjects with Diabetes (A Retrospective Case-Control Study)

<b>Introduction:</b> Diabetes mellitus (DM) is associated with a high risk of chronic degenerative Achilles (AT) and Patellar (PT) tendinopathies and ruptures. Growth factors (GFs) synthesis in diabetics is substantially decreased in human connective tissues, including in tendons. Platelet Rich Plasma (PRP), which is enriched in GFs, might prove of great help in tendon healing. The aim of the study was to assess whether pre-existent DM or Impaired Glucose Tolerance (IGT) could influence the clinical outcome in subjects undergoing PRP treatment. <b>Methods:</b> Sixty subjects with diabetes/pre-diabetes and sixty euglycemic controls, matched for sex and age, were enrolled. Patients suffering from proximal insertional PT and mid-portion AT, treated with PRP therapy, were included in the study. To assess the basal status and the efficacy of the therapy after 3 and 6 months, the Victorian Institute of Sport Assessment (VISA) questionnaire and the Ultrasound methodology study were used. Patient satisfaction was assessed by means of the Likert Scale. <b>Results:</b> In the population study at 6 months, the mean VISA-score increased (8.92 ± 0.67; <i>p</i>-value < 0.001). The improvement in the diabetic group was less evident compared to the controls (-2.76 ± 0.95; <i>p</i>-value = 0.003). Even though the improvement was poor, it was still significant. MCID analysis revealed that diabetics had higher risk of therapeutic unsuccess. Logistic regression analysis was applied to assess factors associated with unsatisfactory results (Likert-scale) of PRP treatment: AT (O.R.: 3.05; 95%CI: 1.40-6.64; <i>p</i>-value = 0.005), higher BMI values (O.R.: 1.02; 95%CI: 1.01-1.04; <i>p</i>-value = 0.01), and lower VISA score values at baseline (O.R.: 0.95; 95%CI: 0.90-0.99; <i>p</i>-value = 0.04). <b>Conclusions:</b> PRP treatment in AT and PT chronic tendinopathies resulted in less favorable results in subjects with diabetes compared with euglycemic subjects. Moreover, the subjects with PT showed better results than those with AT.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2024-09-13
DOI
https://doi.org/10.3390/jcm13185443
Citations
1
Primary Topic
Tendon Structure and Treatment
Type
article
Field-Weighted Citation Impact
0.48
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Platelet Rich Plasma Therapy in Achilles and Patellar Tendinopathies: Outcomes in Subjects with Diabetes (A Retrospective Case-Control Study)

Angelo Di Iorio, Raffaello Pellegrino, Michele Abate, Roberto Paganelli et al.
1 citations
Journal of Clinical Medicine
Tendon Structure and Treatment
0.48
article

Platelet Rich Plasma Therapy in Achilles and Patellar Tendinopathies: Outcomes in Subjects with Diabetes (A Retrospective Case-Control Study)

Angelo Di Iorio, Raffaello Pellegrino, Michele Abate, Roberto Paganelli, Vincenzo Salini
article en
1 citations

Abstract

<b>Introduction:</b> Diabetes mellitus (DM) is associated with a high risk of chronic degenerative Achilles (AT) and Patellar (PT) tendinopathies and ruptures. Growth factors (GFs) synthesis in diabetics is substantially decreased in human connective tissues, including in tendons. Platelet Rich Plasma (PRP), which is enriched in GFs, might prove of great help in tendon healing. The aim of the study was to assess whether pre-existent DM or Impaired Glucose Tolerance (IGT) could influence the clinical outcome in subjects undergoing PRP treatment. <b>Methods:</b> Sixty subjects with diabetes/pre-diabetes and sixty euglycemic controls, matched for sex and age, were enrolled. Patients suffering from proximal insertional PT and mid-portion AT, treated with PRP therapy, were included in the study. To assess the basal status and the efficacy of the therapy after 3 and 6 months, the Victorian Institute of Sport Assessment (VISA) questionnaire and the Ultrasound methodology study were used. Patient satisfaction was assessed by means of the Likert Scale. <b>Results:</b> In the population study at 6 months, the mean VISA-score increased (8.92 ± 0.67; <i>p</i>-value < 0.001). The improvement in the diabetic group was less evident compared to the controls (-2.76 ± 0.95; <i>p</i>-value = 0.003). Even though the improvement was poor, it was still significant. MCID analysis revealed that diabetics had higher risk of therapeutic unsuccess. Logistic regression analysis was applied to assess factors associated with unsatisfactory results (Likert-scale) of PRP treatment: AT (O.R.: 3.05; 95%CI: 1.40-6.64; <i>p</i>-value = 0.005), higher BMI values (O.R.: 1.02; 95%CI: 1.01-1.04; <i>p</i>-value = 0.01), and lower VISA score values at baseline (O.R.: 0.95; 95%CI: 0.90-0.99; <i>p</i>-value = 0.04). <b>Conclusions:</b> PRP treatment in AT and PT chronic tendinopathies resulted in less favorable results in subjects with diabetes compared with euglycemic subjects. Moreover, the subjects with PT showed better results than those with AT.

Journal of Clinical MedicineVol. 13(18)
Libera Università Maria SS. Assunta (IT), University of Chieti-Pescara (IT), Saint Camillus International University of Health and Medical Sciences (IT), IRCCS Ospedale San Raffaele (IT)
No poverty
Openalex Percentile: Top 37%
Tendon Structure and Treatment
0.48
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.